MCA logo
MCA logo

PUBLIC PORTAL

MEDICALLY REVIEWED

World’s First Respiratory Syncytial Virus (RSV) Vaccine Approved by FDA

RSV
The FDA approved Arexvy – the first RSV vaccine for use in the United States in individuals 60 years of age and older. Read more

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: